For the pharmaceutical industry, perhaps the most pressing topic is supply chain traceability, and the role serialization and DSCSA play.
At PACK EXPO Intl. 2016, Tim Kearns, Pharmaceutical and Medical Device Sales Manager, said the focus on serialization and track-and-trace has been on the transactional data between trading partners. “Supply chain traceability is paramount to preserving the integrity of pharmaceutical products and ultimately patient safety,” he noted. “But what about within the walls of your plant?”Videojet demonstrates at PACK EXPO how invisible codes can assist in anti-counterfeiting, track and trace and serialization issues.
In the world of blister packaging, non-destructive testing continues to gain popularity for increasing efficiency and reducing total cost. Traditional methyleneblue dye testing destroys products and/or packaging, promoting environmental waste and causing manufacturers to flush money down the drain.Non-destructive leak detection technology for pharmaceutical blister packaging boasts new and improved test time, data management and test sensitivity.
Igb has developed and industrialized an innovative Child Resistant folding box that looks like a regular folding box and has a locking system. The box comes with a key: without the key, it cannot be opened. If the key is lost, the box can be easily opened by adults with everyday objects like a pen cap. Children under five are not able to do that. The Igb Child Resistant Folding Box is made of a tear-resistant cardboard that children cannot rip open and relocks automatically when closed.Two new innovative folding boxes by Italy's Igb company solve pharma regulation issues with minimal packaging materials and no new equipment costs.
PACK EXPO International and Pharma EXPO 2016 kicked off with a press conference touting the sustained growth of the packaging industry.
Domestic shipments of packaging machinery project to grow at a compound annual growth rate (CAGR) of 2.4 percent reaching $8.5 billion in 2020, according to PACK EXPO owner and producer PMMI, The Association for Packaging and Processing Technologies.U.S. Domestic Shipments of Packaging Machinery Rising to $8.5B by 2020
A recent Bloomberg article explained how dealmakers are treating aging drugs like companies and flipping them. The model is perfectly legal and equally simple: acquire licensing rights, raise the price, and put the licensing back on the market at a hefty premium. Private equity firms are attracted to what some are calling “financial engineering,” because it’s relatively low-risk with a speedy payout.Private equity firms take advantage of soaring drug prices to capitalize on short-term acquisitions.
Coca-Cola and McDonald’s recent foray into retail packaging that consumers can fold into headsets or viewers might be considered “wicked cool,” but packaging equipment displayed in virtual reality also generates excitement by providing vivid color and animated views of machinery in action, often from angles and perspectives that creatively and clearly demonstrate how the equipment looks, runs, and often how easily it can be cleaned or changed over.MultiUse filler and machine used to make transdermal patches and oral filmstrips shown in virtual reality via on-site simulations.
The U.S. continues to be the largest market for pharmaceutical and medical devices, according to PACK EXPO owner and producer PMMI, The Association for Packaging and Processing Technologies. As the global demand for medicines and devices rise, processors are concerned with issues such as changing consumer demographics, regulatory issues, the need for cost containment, advances in 3D printing and updating legacy lines.Demographics, regulatory issues, costs and 3D printing are among processor concerns.
The FDA announced on October 17, 2016 that it has awarded over $23 million to 21 principal investigators for new clinical trial research to develop products for patients with rare diseases, many of which have limited or no treatment options. The awards, to be doled out over the next four years, are given to groups in academia and industry through the Orphan Products Clinical Trials Grants Program.
With 68 grant applications submitted this fiscal year, the 21 grants represent a 31 percent funding rate.The Orphan Products Clinical Trials Grants Program awarded over $23 million in grants to academia and industry. Many of the grants target cancer, pediatric needs.Tags: orphan drugsBiologicsrare diseasesgrantsFDA
In 2015, more than 20 million counterfeit pills and other medications were confiscated in one covert operation, according to “INTERPOL-coordinated operation strikes at organized crime with seizure of 20 million illicit medicines,” INTERPOL, June 18, 2015.
It’s a problem that will continue to plague pharmaceutical companies—and other industries—because criminals can make a lot of money by falsifying drugs that are in high demand, in short supply or are exorbitantly expensive for consumers.ATIP and Covectra arm multiple industries with simple technology to combat product counterfeiting.
Given the rise in population, urbanization, an aging population and an increase in healthcare spending, demand for healthcare products has risen— followed by increased demand for healthcare packaging.
The healthcare packaging market, according to market research company Commodity Inside, is “an essential, though tiny component of the healthcare industry."Global changes in healthcare systems and evolving demographics increase demand for healthcare products and their packaging.
The first premade version of VersaPouch was made possible by Glenroy's proprietary premade-pouch converting technology. Providing a cost-effective alternative to existing form-fill-seal inverted pouches, the premade inverted pouch doesn't require the capital outlay of a new machine.Introduces First Premade VersaPouch that employs a patented closure from AptarGroup.
The U.S. packaging machinery market is comprised of imports, exports, and domestic shipments, and last year was estimated at $10 billion. Food and beverage may dominate the market for U.S. packaging shipments, but pharmaceuticals aren’t far behind; it’s tied for the fastest growing sector, with a CAGR of 2.8%.PMMI’s inside look at the current state of the U.S. packaging machinery market and forecast through 2020.
Klöckner Pentaplast’s Pentalabel® shrink film line has expanded to include a new light blocking film, Pentalabel® eklipse™.
This product introduces maximum light blocking properties into the film process and satisfies a market need for films that are cost-effective, process efficient and improve light barrier characteristics.Light blocking properties satisfy a market need for films that are cost-effective, process efficient and improve light barrier characteristics.
It’s no secret the world is dependent on China’s drug production; an estimated 80 percent of drug ingredients are produced in India and China. A November 2ndarticle from Consumer Affairs says one Chinese drug company is hiding ingredients and blocking U.S. inspectors from doing their jobs.U.S. regulators barred from inspections as they take on Chinese pharmaceutical companies with questionable practices.